21211 ⎘
Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen Cells
TREATMENT AND/OR PREVENTION OF AN INFECTION BY MONO/DIVALENT AND POLYVALENT ANTIGEN PARTICLE-MEDIATED IMMUNE RESPONSES
#2Personalized Anticancer Vaccine Comprising Glycoengineered Tumour Cells or Tumour Cell Fragments
#3TREATMENT OF HAEMATOLOGICAL MALIGNANCIES
#4METHODS TO STIMULATE IMMUNE RESPONSES TO MUTANT RAS USING ANUCLEATE CELLS
#5METHODS TO STIMULATE IMMUNE RESPONSES TO MUTANT RAS USING NUCLEATED CELLS
#6INTRACELLULAR DELIVERY OF BIOMOLECULES TO INDUCE TOLERANCE
#7VACCINES FOR IN VIVO EXPRESSION OF NUCLEIC ACIDS AND METHODS OF USING THE SAME
#8SMALLPOX VACCINE FOR CANCER TREATMENT
#9ARTIFICIAL ADJUVANT VECTOR CELL CAPABLE OF INDUCING IMMUNE RESPONSE TO CORONAVIRUS, PHARMACEUTICAL COMPOSITION CONTAINING SAID CELL, AND USE APPLICATIONS OF SAID CELL AND SAID PHARMACEUTICAL COMPOSITION
#10MULTIPLE SCLEROSIS ASSOCIATED AUTOANTIGENS, AND USE THEREOF IN THERAPY AND DIAGNOSIS
#11SILICIFIED CELL REPLICAS, METHODS OF MAKING, AND METHODS OF USING
#12METHOD OF GENERATING VACCINES
#13Personalized Immunogenic Compositions and Methods for Producing and Using Same
#14MODIFIED MYCOBACTERIUM BOVIS VACCINES
#15LIVE SALMONELLA TYPHI VECTORS ENGINEERED TO EXPRESS CANCER PROTEIN ANTIGENS AND METHODS OF USE THEREOF
#16Steroid acid-based immunogen enhancers
#17COMBINATION THERAPY WITH MODIFIED PBMCS AND AN IMMUNOCONJUGATE
#18Smallpox vaccine for cancer treatment
#19Steroid acid-based immunogen enhancers
#20TREATMENT OF HAEMATOLOGICAL MALIGNANCIES
#21Covalently modified antigens for improved immune response and/or stability
#22ENCAPSULATED GLYCOLIPID ANTIGENS FOR TREATMENT OF NEOPLASTIC DISEASES
#23Viral vaccines for in vivo expression of a nucleic acid encoding an immunogenic peptide and methods of using the same
#24PRIMING OF AN IMMUNE RESPONSE
#25Yeast-brachyury immunotherapeutic compositions
#26MULTIPLE SCLEROSIS ASSOCIATED AUTOANTIGENS, AND USE THEREOF IN THERAPY AND DIAGNOSIS
#27Smallpox vaccine for cancer treatment
#28METHODS OF TREATING HEMATOLOGICAL DISORDERS, SOLID TUMORS, OR INFECTIOUS DISEASES USING NATURAL KILLER CELLS
#29Compositions and methods for TCR reprogramming using fusion proteins
#30-activated B cell platforms and methods thereof
#31Methods for obtaining pluripotent adult olfactory stem cells from an olfactory mucosa tissue
#32Silicified cell replicas, methods of making, and methods of using
#33Treatment of haematological malignancies
#34Augmenting the immune response by promoting cell death of immune cells
#35Yeast-brachyury immunotherapeutic compositions
#36Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
#37Cancer vaccines and vaccination methods
#38Polypeptide and use thereof
#39Compositions and methods for TCR reprogramming using fusion proteins
#40Intracellular delivery of biomolecules to induce tolerance
#41Smallpox vaccine for cancer treatment
#42Method for prevention or treatment of one or more of diseases relevant to the protein in the protein-cell conjugate, malignant tumors, infectious diseases caused by pathogenic microorganisms and autoimmune diseases
#43Compositions and methods for the treatment or prevention of hepatitis B virus infection
#44Compositions and methods for TCR reprogramming using fusion proteins
#45Modified yeast-brachyury immunotherapeutic compositions
#46Methods for treating a brain tissue damage by cultured adult pluripotent olfactory stem cells
#47Augmenting the immune response by promoting cell death of immune cells
#48Mycobacterial antigen composition
#49-activated B cell platforms and methods thereof
#50Compositions and methods for treatment of cancer
#51METHODS OF TREATING HEMATOLOGICAL DISORDERS, SOLID TUMORS, OR INFECTIOUS DISEASES USING NATURAL KILLER CELLS
#52Engineered exosomes for the delivery of bioactive cargo using transmembrane tetraspanins
#53Protein-Coupled Red Blood Cell Compositions and Methods of Their Use
#54PRIMING OF AN IMMUNE RESPONSE
#55Self-antigen displaying nanoparticles targeting auto-reactive immune factors and uses thereof
#56Yeast-brachyury immunotherapeutic compositions
#57Combinatorial platform for the display of surface adjuvants and antigens
#58Vaccine
#59Smallpox vaccine for cancer treatment
#60Compositions and methods for the treatment or prevention of hepatitis B virus infection
#61Protein-cell conjugate, preparation method and use thereof
#62Compositions and methods of enhancing immune responses
#63Yeast-brachyury immunotherapeutic compositions
#64Vaccine formulation for ocular immunization
#65Cancer vaccines and vaccination methods
#66Augmenting the immune response by promoting cell death of immune cells
#67Methods and compositions for treating breast cancer with dendritic cell vaccines
#68Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
#69Compositions and methods for the treatment or prevention of hepatitis B virus infection
#70Vaccine vectors and methods of enhancing immune responses
#71Bacterial biofilm matrix as a platform for protein delivery
#72Yeast-based therapeutic for chronic hepatitis B infection
#73Dual delivery system for heterologous antigens
#74Dual delivery system for heterologous antigens
#75Compositions and methods for the treatment or prevention of hepatitis B virus infection
#76CANCER VACCINES AND VACCINATION METHODS
#77OVARIAN CANCER VACCINES AND VACCINATION METHODS
#78Yeast-based therapeutic for chronic hepatitis B infection
#79Bivalent vaccine for marine fish and method for making the same
#80Yeast-Brachyury immunotherapeutic compositions
#81Vaccine vectors and methods of enhancing immune responses
#82CLOSTRIDIUM TAENIOSPORUM SPORES AND SPORE APPENDAGES AS SURFACE DISPLAY HOSTS, DRUG DELIVERY DEVICES, AND NANOBIOTECHNOLOGICAL STRUCTURES
#83CULTURED MYELOID DENDRITIC CELLS ISOLATED FROM PEYER'S PATCHES AND USES THEREOF
#84PRIMING OF AN IMMUNE RESPONSE
#85Combinatorial analysis and repair
#86Antigenic compositions and use of same in the targeted delivery of nucleic acids
#87DUAL DELIVERY SYSTEM FOR HETEROLOGOUS ANTIGENS
#88Methods, compositions and kits for vegetative cell-based vaccines and spore-based vaccines
#89Compositions and methods of enhancing immune responses
#90Device including bone cage and method for treatment of disease in a subject
#91Device including bone cage and method for treatment of disease in a subject
#92MODIFIED CELLS FOR TARGETED CELL TRAFFICKING AND USES THEREOF
#93Light-mediated anti-cell proliferative compositions and methods
#94Carrier
#95NOVEL PRIME-BOOST COMBINATIONS OF ATTENUATED MYCOBACTERIUM
#96Pharmaceutical Composition Comprising a Bacterial Cell Displaying a Heterologous Proteinaceous Compound
#97Composition having antitumor effect
#98METHODS AND COMPOSITIONS FOR INCREASED PRIMING OF T-CELLS THROUGH CROSS-PRESENTATION OF EXOGENOUS ANTIGENS
#99Human papilloma virus immunoreactive peptides
#100Integrated viral complexes, methods of production thereof, vaccines containing same and methods of use thereof
#101Compositions comprising structurally stable conjugate molecules
#102Molecular vaccines employing nucleic acid encoding anti-apoptotic proteins
#103Use of allogenic or syngenic major histocompatibility complex (MHC) molecules as universal adjuvants for vaccines against neoplastic disease, infection and autoimmune disease
#104Composition for delivering an agent to a target cell and uses thereof
#105Method for tumor treatment using infusion of xenogeneic cells to induce hyperacute rejection and innocent bystander effect
#106Composition for delivering an agent to a target cell and uses thereof
#107Covalently modified antigens for improved immune response and/or stability